Pandemic Darlings The pandemic economy, in original documents
Home Court filings Apter v. Department of Health and Human Services — S.D. Tex., Galveston Exhibit 2 — FDA Ivermectin FAQ — Apter v. HHS

Court filing

Exhibit 2 — FDA Ivermectin FAQ — Apter v. HHS

Summary

Exhibit 2, filed as Document 1-2 on 06/02/22 in Case 3:22-cv-00184 (TXSD), is a printout of the FDA web page "FAQ: COVID-19 and Ivermectin Intended for Animals." In question-and-answer form it says ivermectin is not approved for the prevention or treatment of COVID-19 and answers No to whether there is an emergency use authorization for that purpose. It describes the approved human uses, tablets for some parasitic worms and topical formulations for headlice and rosacea, and the approved animal uses, and says people should never take animal drugs. It lists possible side effects and describes a cross-agency task force and FDA and Federal Trade Commission warning letters aimed at fraudulent COVID-19 products.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Filed June 2, 2022 in Apter v. Department of Health and Human Services; one of 69 filings from this case.

Record facts

CourtU.S. District Court for the Southern District of Texas, Galveston Division
Filed2022-06-02

Cite this document

“Exhibit 2 — FDA Ivermectin FAQ — Apter v. HHS.” U.S. District Court for the Southern District of Texas, Galveston Division, No. 3:22-cv-00184, Doc. 1-2, filed 2022-06-02. Archived at Pandemic Darlings, https://pandemicdarlings.com/court-filings/apter-v-hhs/2022-06-02-exhibit-2-fda-ivermectin-faq/, SHA-256 cbd7db29c2c297acd3f740a9b5e8eb04ffae222570d74a2ae29fa8b77d70eeef.

Search CourtListener for this docket number

Full text

Case 3:22-cv-00184 Document 1-2 Filed on 06/02/22 in TXSD Page 1 of 3
Exhibit 2
Case 3:22-cv-00184 Document 1-2 Filed on 06/02/22 in TXSD Page 2 of 3
FAQ: COVID-19 and Ivermectin Intended for Animals
Español (/animal-veterinary/product-safety-information/preguntas-mas-comunes-el-covid-19-y-la-ivermectina-prevista-para-animales)
Q: Should I take ivermectin to prevent or treat COVID-19?
A: No. While there are approved uses for ivermectin in people and animals, it is not approved for the prevention or treatment of COVID-19. You
should not take any medicine to treat or prevent COVID-19 unless it has been prescribed to you by your health care provider and acquired from a
legitimate source.
A recently released research article (https://pdf.sciencedirectassets.com/271065/AIP/1-s2.0-S0166354220302011/main.pdf?X-Amz-
Date=20200406T215853Z&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-
[illegible]
Credential=ASIAQ3PHCVTY32VGY2LR%2F20200406%2Fus-east-1%2Fs3%2Faws4_request&type=client&tid=prr-2af71973-98c2-4d5f-954c-
o2bc9e60ea14&sid=45be74a6676495419c1ba842da478030ef40gxrqa&pii=S0166354220302011&X-Amz-SignedHeaders=host&X-Amz-Security-
[illegible]
Amz-Expires=300&hash=[illegible] (http://www.fda.gov/about-fda/website-
policies/website-disclaimer) described the effect of ivermectin on SARS-CoV-2 in a laboratory setting. These types of laboratory studies are
commonly used at an early stage of drug development. Additional testing is needed to determine whether ivermectin might be appropriate to prevent
or treat coronavirus or COVID-19.
Q: Is there an emergency use authorization for ivermectin in the U.S. to prevent or treat
coronavirus or COVID-19?
A: No. FDA has created a special emergency program for possible therapies, the Coronavirus Treatment Acceleration Program (/drugs/coronavirus-
covid-19-drugs/coronavirus-treatment-acceleration-program-ctap) (CTAP). It uses every available method to move new treatments to patients as
quickly as possible, while at the same time finding out whether they are helpful or harmful. We continue to support clinical trials that are testing new
treatments for COVID so that we can gain valuable knowledge about their safety and effectiveness.
Q: What is ivermectin approved for in the U.S.?
A: Ivermectin tablets are approved for use in humans for the treatment of some parasitic worms (intestinal strongyloidiasis and onchocerciasis) and
ivermectin topical formulations are approved for human use by prescription only for the treatment of external parasites such as headlice and for skin
conditions such as rosacea.
Ivermectin is FDA-approved for use in animals for prevention of heartworm disease in some small animal species, and for treatment of certain
internal and external parasites in various animal species. People should never take animal drugs, as the FDA has only evaluated their safety and
effectiveness in the particular species for which they are labeled. Using these products in humans could cause serious harm.
Q: Is there any danger to humans taking ivermectin?
A: There are approved uses for ivermectin in people and animals but it is not approved for the prevention or treatment of COVID-19. You should not
take any medicine to treat or prevent COVID-19 unless it has been prescribed to you by your health care provider and acquired from a legitimate
source.
Some of the side-effects that may be associated with ivermectin include skin rash, nausea, vomiting, diarrhea, stomach pain, facial or limb swelling,
neurologic adverse events (dizziness, seizures, confusion), sudden drop in blood pressure, severe skin rash potentially requiring hospitalization and
liver injury (hepatitis). Laboratory test abnormalities include decrease in white cell count and elevated liver tests. Any use of ivermectin for the
prevention or treatment of COVID-19 should be avoided as its benefits and safety for these purposes have not been established. Data from clinical
trials are necessary for us to determine whether ivermectin is safe and effective in treating or preventing COVID-19.
Q: What should I do if the ivermectin products I purchase for use in my animals are not available
at my typical retailer?
A: Ivermectin is an important part of a parasite control program for certain species and should only be given to animals for approved uses or as
prescribed by a veterinarian in compliance with the requirements for extra-label drug use. Due to potentially elevated interest in ivermectin
following the new research, some products may not be available. If you are having difficulty locating a particular ivermectin product for your
animal(s), the FDA recommends that you consult with your veterinarian.
Q: What is the FDA doing to protect people from fraudulent COVID-19 products?
https://www.fda.gov/animal-veterinary/product-safety-information/faq-covid-19-and-ivermectin-intended-animals 1/2
Case 3:22-cv-00184 Document 1-2 Filed on 06/02/22 in TXSD Page 3 of 3
A: We have established a cross-agency task force dedicated to closely monitoring for fraudulent COVID-19 products. We have reached out to major
retailers to ask for their help in monitoring online marketplaces for fraudulent COVID-19 products. Products sold are subject to FDA investigation
and potential enforcement action if they claim to prevent, diagnose, treat, or cure COVID-19 and have not demonstrated safety and effectiveness for
that intended use. The task force has already worked with retailers to remove dozens of these types of product listings online.
The FDA and the Federal Trade Commission (FTC) issue warning letters to companies that violate federal law and pose significant risks to patient
health by selling unapproved products with fraudulent claims to treat or prevent COVID-19. View the warning letters (/consumers/health-fraud-
scams/fraudulent-coronavirus-disease-2019-covid-19-products#Warning Letter Table) for more information.
Additional Information
FDA Letter to Stakeholders: Do Not Use Ivermectin Intended for Animals as Treatment for COVID-19 in Humans (/animal-veterinary/product-
safety-information/fda-letter-stakeholders-do-not-use-ivermectin-intended-animals-treatment-covid-19-humans)
Why You Should Not Use Ivermectin to Treat or Prevent COVID-19 (/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-
prevent-covid-19)
https://www.fda.gov/animal-veterinary/product-safety-information/faq-covid-19-and-ivermectin-intended-animals 2/2


File and source

File
gov.uscourts.txsd.1875135.1.2.pdf
Size
1,942,313 bytes
SHA-256
cbd7db29c2c297acd3f740a9b5e8eb04ffae222570d74a2ae29fa8b77d70eeef
Our copy
gov.uscourts.txsd.1875135.1.2.pdf
Original
archive.org
Back to top